Live Breaking News & Updates on Antony Mattessich|Page 8

Stay updated with breaking news from Antony mattessich. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ocular Therapeutix adds two executives to leadership team

Ocular Therapeutix (Nasdaq:OCUL) announced today that it made three additions to its executive leadership team. ....

Peter Kaiser , Antony Mattessich , Michael Goldstein , Rabia Gurses Ozden , Cleveland Clinic Lerner College Of Medicine , Cole Eye Institute , Ophthalmology Research , Ocular Therapeutix , Massachusetts Based Ocular Therapeutix , Chaney Family Endowed Chair , Cleveland Clinic Lerner College , Cole Eye , Nightstar Therapeutics , Therapeutix President ,

Ocular Therapeutix™ Announces Organizational Changes to Support Development for Retinal Diseases

Peter K. Kaiser, M.D., a world-renowned ophthalmologist and retinal disease expert, to serve as Chief Medical Advisor – RetinaRabia Gurses Ozden, M.D. promoted to Chief Medical OfficerMichael Goldstein, M.D. to transition from Chief Medical Officer and President Ophthalmology to Chief Strategy AdvisorBEDFORD, Mass.-. ....

United States , Scott Corning , Antony Mattessich , Gurses Ozden , Michael Goldstein , Rabia Gurses Ozden , Chris Brinzey , Peterk Kaiser , Lewr Wasserman , Donald Notman , American Society Of Retina Specialists Honor , Bascom Palmer Eye Institute , Ophthalmology Research , Ocular Therapeutix Inc , Company On , Cleveland Clinic Foundation , Clinical Development , Editor Of International Ophthalmology Clinics , Senior Leadership Team , Cleveland Clinic Lerner College Of Medicine , Harvard Medical School , Macula Society Young Investigator Award , Company Senior Vice , Exchange Commission , Research To Prevent Blindness , Akouos Inc ,

Ocular Therapeutix posts mixed-bag Q1 results

Ocular Therapeutix (NSDQ:OCUL) posted first-quarter results that beat the earnings consensus on Wall Street but missed revenue estimates. ....

United States , Antony Mattessich , Ocular Therapeutix , Wall Street ,

Ocular Therapeutix misses on Q4 projections

Ocular Therapeutix (NSDQ:OCUL) shares ticked up today despite fourth-quarter results that missed the consensus forecast. ....

United States , Antony Mattessich , Massdevice Medtech , Ocular Therapeutix , Wall Street , Therapeutix President ,

Ocular Therapeutix™ Announces Appointment of Karen-Leigh Edwards as Senior Vice President of Technical Operations

Ocular Therapeutix™ Announces Appointment of Karen-Leigh Edwards as Senior Vice President of Technical Operations
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.

Antony Mattessich , University Of Kansas , Alexion Pharmaceuticals , Biogen Inc , Ocular Therapeutix Inc , Exchange Commission , University Of London , Sloan School Of Management , University Of The West Indies , Karen Leigh Edwards , Senior Vice President , Chief Executive Officer , External Manufacturing , Bioinorganic Chemistry , Inorganic Chemistry , Analytical Chemistry , Ocular Therapeutix , Prescription Drug User Fee Act , Resure Sealant , Private Securities Litigation Reform Act ,